GAMMA Investing’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.75M Buy
3,357
+60
+2% +$32.9K 0.06% 257
2026
Q2
$1.74M Buy
3,297
+229
+7% +$128K 0.06% 243
2026
Q1
$1.72M Buy
3,068
+77
+3% +$49.4K 0.08% 220
2025
Q4
$2.02M Buy
2,991
+264
+10% +$180K 0.1% 164
2025
Q3
$1.74M Buy
2,727
+292
+12% +$177K 0.1% 175
2025
Q2
$1.31M Buy
2,435
+248
+11% +$119K 0.08% 213
2025
Q1
$918K Buy
2,187
+654
+43% +$284K 0.07% 259
2024
Q4
$634K Buy
1,533
+49
+3% +$21.5K 0.05% 302
2024
Q3
$750K Buy
1,484
+314
+27% +$153K 0.07% 245
2024
Q2
$570K Buy
1,170
+575
+97% +$289K 0.08% 238
2024
Q1
$321K Buy
595
+85
+17% +$46.5K 0.07% 280
2023
Q4
$263K Buy
+510
New +$239K 0.07% 256

Other funds holding IDXX

GAMMA Investing's IDXX Position: Q3 2026 in Review

GAMMA Investing increased its Idexx Laboratories (IDXX) stake by 1.8% in Q3 2026, buying an estimated $32.9K and bringing the position to 3,357 shares worth $1.75M. The position accounts for 0.06% of the portfolio, ranked #257.

GAMMA Investing first reported a position in IDXX in Q4 2023 and has held it in 12 quarters since. The position peaked at $2.02M in Q4 2025. 33 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

  • GAMMA Investing held 3,357 shares of Idexx Laboratories worth $1.75M as of Q3 2026.
  • GAMMA Investing bought 60 Idexx Laboratories shares in Q3 2026, an estimated $32.9K.
  • Idexx Laboratories made up 0.06% of GAMMA Investing's portfolio in Q3 2026, its #257 holding.
  • GAMMA Investing first reported a position in Idexx Laboratories in Q4 2023 and has held it in 12 quarters since.
  • GAMMA Investing's Idexx Laboratories position peaked at $2.02M in Q4 2025.
  • 33 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.